MABDX
Price
$12.14
Change
-$0.02 (-0.16%)
Updated
Aug 3 closing price
Net Assets
2.2B
VTBNX
Price
$9.37
Change
+$0.02 (+0.21%)
Updated
Aug 3 closing price
Net Assets
386.56B
Interact to see
Advertisement

MABDX vs VTBNX

MABDX vs VTBNX Comparison Chart in %
View a ticker or compare two or three
VS
MABDX vs. VTBNX commentary
Aug 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MABDX is a Hold and VTBNX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTBNX has more cash in the bank: 387B vs. MABDX (2.2B). MABDX (4.20) and VTBNX (4.15) have matching dividends . MABDX was incepted earlier than VTBNX: MABDX (42 years) vs VTBNX (17 years). MABDX (0.45) is less costly to investors than VTBNX (0.02). VTBNX is a more actively managed with annual turnover of: 107.00 vs. MABDX (34.27). MABDX has a lower initial minimum investment than VTBNX: MABDX (1000) vs VTBNX (5000000). MABDX annual gain was more profitable for investors over the last year : 1.81 vs. VTBNX (-2.30). MABDX return over 5 years is better than : -3.32 vs. VTBNX (-17.07).
MABDXVTBNXMABDX / VTBNX
Total Expense Ratio0.450.022,250%
Annual Report Gross Expense Ratio0.450.022,250%
Fund Existence42 years17 years-
Gain YTD-0.853-3.00828%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.2B387B1%
Annual Yield % from dividends4.204.15101%
Returns for 1 year1.81-2.30-79%
Returns for 3 years12.040.1111,241%
Returns for 5 years-3.32-17.0719%
Returns for 10 years11.40-14.19-80%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AARD7.080.48
+7.27%
Aardvark Therapeutics Inc
GILT11.700.65
+5.88%
Gilat Satellite Networks Ltd
TPR155.633.26
+2.14%
Tapestry
COLD14.110.02
+0.14%
Americold Realty Trust
QNRX4.45N/A
N/A
Quoin Pharmaceuticals Ltd